All StatesOhioHamilton CountyGreg Landsman › Evidence
Bill Jul 21, 2026

To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 9774 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 9774 To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES July 20, 2026 Mr. Latta (for himself and Mr. Landsman) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. PRIORITY NONPRESCRIPTION DRUGS. (a) In General.--The Federal Food, Drug, and Cosmetic Act is amended by inserting after section 506L (21 U.S.C. 356l) the following: ``SEC. 506M. PRIORITY NONPRESCRIPTION DRUGS. ``(a) In General.-- ``(1) Designation.--The Secretary may, at the request of the sponsor of a nonprescription drug, designate as a priority nonprescription drug under this section a drug intended for nonprescription use that is subject to an application submitted (or to be submitted) under section 505(b), if the Secretary determines that the drug meets the criteria specified in subsection (d). ``(2) Nonprescription defined.--In this section, the term `nonprescription' means, with respect to a drug, that such drug is not subject to section 503(b)(1). ``(b) Request for Designation.--The sponsor of a drug subject to a pending application under section 505(b) for nonprescription use may request that the Secretary designate the drug as a priority nonprescription drug. ``(c) Designation.--Not later than 60 calendar days after the receipt of a request under subsection (b), the Secretar

https://www.congress.gov/bill/119th-congress/house-bill/9774
Greg Landsman U.S. Representative Robert Latta U.S. Representative Sponsor
Share on X Share on Facebook
← Back to Greg Landsman's profile